Back
Lexicon Pharmaceuticals, Inc. Vs. Ziff Davis, Inc. Industry Stock Comparison
Sell
36
LXRX
Lexicon Pharmaceuticals, Inc.
Last Price:
$1.59
Seasonality Move:
-4.3%
Sell
39
ZD
Ziff Davis, Inc.
Last Price:
$43.22
Seasonality Move:
6.2%
Sell
36
Lexicon Pharmaceuticals, Inc. (LXRX)
is a Sell
Is Lexicon Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Lexicon Pharmaceuticals, Inc. [LXRX] share price is $1.59. The Score for LXRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
LXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ziff Davis, Inc. (ZD)
is a Sell
Is Ziff Davis, Inc. a Buy, Sell or Hold?
-
The current Ziff Davis, Inc. [ZD] share price is $43.19. The Score for ZD is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals, Inc.'s stock price today?
-
The Lexicon Pharmaceuticals, Inc. share price today is $1.59The current trend is relatively stagnant and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.
ZD Stock Price Chart
What is Ziff Davis, Inc.'s stock price today?
-
The Ziff Davis, Inc. share price today is $43.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZD is experiencing buying pressure, which is a positive indicator for future bullish movement.
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 50.32 | Buy |
| Chaikin Money Flow: | -1387449 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.57 - 1.69) | Sell |
| Bollinger Bands (100): | (1.23 - 1.59) | Buy |
ZD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 62.6 | Buy |
| Chaikin Money Flow: | 511387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.75 - 44.97) | Buy |
| Bollinger Bands (100): | (31.29 - 40.27) | Buy |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.62 | Sell |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.52 | Buy |
| 200-day SMA: | 1.3 | Buy |
| 8-day EMA: | 1.53 | Buy |
| 20-day EMA: | 1.13 | Buy |
| 50-day EMA: | 0.61 | Buy |
| 200-day EMA: | 0.18 | Buy |
ZD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.69 | Buy |
| 20-day SMA: | 41.91 | Buy |
| 50-day SMA: | 37.19 | Buy |
| 200-day SMA: | 35.41 | Buy |
| 8-day EMA: | 42.46 | Buy |
| 20-day EMA: | 41.13 | Buy |
| 50-day EMA: | 38.51 | Buy |
| 200-day EMA: | 37.17 | Buy |
Lexicon Pharmaceuticals, Inc. Earnings Growth & LXRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.03 per share.
Ziff Davis, Inc. Earnings Growth & ZD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.50 per share, an increase this year of $0.19 per share, and an increase next year of $0.48 per share.
Lexicon Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ziff Davis, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||